Global Erythropoietin (EPO) Drugs Market Research Report 2022

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Erythropoietin (EPO) Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Epoetin-alfa
1.2.3 Darbepoetin-alfa
1.3 Market by Application
1.3.1 Global Erythropoietin (EPO) Drugs Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Erythropoietin (EPO) Drugs Market Perspective (2017-2028)
2.2 Erythropoietin (EPO) Drugs Growth Trends by Region
2.2.1 Erythropoietin (EPO) Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Erythropoietin (EPO) Drugs Historic Market Size by Region (2017-2022)
2.2.3 Erythropoietin (EPO) Drugs Forecasted Market Size by Region (2023-2028)
2.3 Erythropoietin (EPO) Drugs Market Dynamics
2.3.1 Erythropoietin (EPO) Drugs Industry Trends
2.3.2 Erythropoietin (EPO) Drugs Market Drivers
2.3.3 Erythropoietin (EPO) Drugs Market Challenges
2.3.4 Erythropoietin (EPO) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Erythropoietin (EPO) Drugs Players by Revenue
3.1.1 Global Top Erythropoietin (EPO) Drugs Players by Revenue (2017-2022)
3.1.2 Global Erythropoietin (EPO) Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Erythropoietin (EPO) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Erythropoietin (EPO) Drugs Revenue
3.4 Global Erythropoietin (EPO) Drugs Market Concentration Ratio
3.4.1 Global Erythropoietin (EPO) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Erythropoietin (EPO) Drugs Revenue in 2021
3.5 Erythropoietin (EPO) Drugs Key Players Head office and Area Served
3.6 Key Players Erythropoietin (EPO) Drugs Product Solution and Service
3.7 Date of Enter into Erythropoietin (EPO) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Erythropoietin (EPO) Drugs Breakdown Data by Type
4.1 Global Erythropoietin (EPO) Drugs Historic Market Size by Type (2017-2022)
4.2 Global Erythropoietin (EPO) Drugs Forecasted Market Size by Type (2023-2028)
5 Erythropoietin (EPO) Drugs Breakdown Data by Application
5.1 Global Erythropoietin (EPO) Drugs Historic Market Size by Application (2017-2022)
5.2 Global Erythropoietin (EPO) Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Erythropoietin (EPO) Drugs Market Size (2017-2028)
6.2 North America Erythropoietin (EPO) Drugs Market Size by Country (2017-2022)
6.3 North America Erythropoietin (EPO) Drugs Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Erythropoietin (EPO) Drugs Market Size (2017-2028)
7.2 Europe Erythropoietin (EPO) Drugs Market Size by Country (2017-2022)
7.3 Europe Erythropoietin (EPO) Drugs Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Erythropoietin (EPO) Drugs Market Size (2017-2028)
8.2 Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Country (2017-2022)
8.3 Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Erythropoietin (EPO) Drugs Market Size (2017-2028)
9.2 Latin America Erythropoietin (EPO) Drugs Market Size by Country (2017-2022)
9.3 Latin America Erythropoietin (EPO) Drugs Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Erythropoietin (EPO) Drugs Market Size (2017-2028)
10.2 Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Country (2017-2022)
10.3 Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Erythropoietin (EPO) Drugs Introduction
11.1.4 Pfizer Revenue in Erythropoietin (EPO) Drugs Business (2017-2022)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Erythropoietin (EPO) Drugs Introduction
11.2.4 Roche Revenue in Erythropoietin (EPO) Drugs Business (2017-2022)
11.2.5 Roche Recent Development
11.3 Amgen
11.3.1 Amgen Company Detail
11.3.2 Amgen Business Overview
11.3.3 Amgen Erythropoietin (EPO) Drugs Introduction
11.3.4 Amgen Revenue in Erythropoietin (EPO) Drugs Business (2017-2022)
11.3.5 Amgen Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Erythropoietin (EPO) Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Erythropoietin (EPO) Drugs Business (2017-2022)
11.4.5 Johnson & Johnson Recent Development
11.5 Kyowa Kirin
11.5.1 Kyowa Kirin Company Detail
11.5.2 Kyowa Kirin Business Overview
11.5.3 Kyowa Kirin Erythropoietin (EPO) Drugs Introduction
11.5.4 Kyowa Kirin Revenue in Erythropoietin (EPO) Drugs Business (2017-2022)
11.5.5 Kyowa Kirin Recent Development
11.6 Shanghai Dahua Pharmaceutical
11.6.1 Shanghai Dahua Pharmaceutical Company Detail
11.6.2 Shanghai Dahua Pharmaceutical Business Overview
11.6.3 Shanghai Dahua Pharmaceutical Erythropoietin (EPO) Drugs Introduction
11.6.4 Shanghai Dahua Pharmaceutical Revenue in Erythropoietin (EPO) Drugs Business (2017-2022)
11.6.5 Shanghai Dahua Pharmaceutical Recent Development
11.7 JCR Pharmaceuticals
11.7.1 JCR Pharmaceuticals Company Detail
11.7.2 JCR Pharmaceuticals Business Overview
11.7.3 JCR Pharmaceuticals Erythropoietin (EPO) Drugs Introduction
11.7.4 JCR Pharmaceuticals Revenue in Erythropoietin (EPO) Drugs Business (2017-2022)
11.7.5 JCR Pharmaceuticals Recent Development
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Detail
11.8.2 Teva Pharmaceuticals Business Overview
11.8.3 Teva Pharmaceuticals Erythropoietin (EPO) Drugs Introduction
11.8.4 Teva Pharmaceuticals Revenue in Erythropoietin (EPO) Drugs Business (2017-2022)
11.8.5 Teva Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Erythropoietin (EPO) Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Epoetin-alfa
Table 3. Key Players of Darbepoetin-alfa
Table 4. Global Erythropoietin (EPO) Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Erythropoietin (EPO) Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Erythropoietin (EPO) Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Erythropoietin (EPO) Drugs Market Share by Region (2017-2022)
Table 8. Global Erythropoietin (EPO) Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Erythropoietin (EPO) Drugs Market Share by Region (2023-2028)
Table 10. Erythropoietin (EPO) Drugs Market Trends
Table 11. Erythropoietin (EPO) Drugs Market Drivers
Table 12. Erythropoietin (EPO) Drugs Market Challenges
Table 13. Erythropoietin (EPO) Drugs Market Restraints
Table 14. Global Erythropoietin (EPO) Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Erythropoietin (EPO) Drugs Market Share by Players (2017-2022)
Table 16. Global Top Erythropoietin (EPO) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erythropoietin (EPO) Drugs as of 2021)
Table 17. Ranking of Global Top Erythropoietin (EPO) Drugs Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Erythropoietin (EPO) Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Erythropoietin (EPO) Drugs Product Solution and Service
Table 21. Date of Enter into Erythropoietin (EPO) Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Erythropoietin (EPO) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Erythropoietin (EPO) Drugs Revenue Market Share by Type (2017-2022)
Table 25. Global Erythropoietin (EPO) Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Erythropoietin (EPO) Drugs Revenue Market Share by Type (2023-2028)
Table 27. Global Erythropoietin (EPO) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Erythropoietin (EPO) Drugs Revenue Market Share by Application (2017-2022)
Table 29. Global Erythropoietin (EPO) Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Erythropoietin (EPO) Drugs Revenue Market Share by Application (2023-2028)
Table 31. North America Erythropoietin (EPO) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Erythropoietin (EPO) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Erythropoietin (EPO) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Erythropoietin (EPO) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Erythropoietin (EPO) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Erythropoietin (EPO) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 41. Pfizer Company Detail
Table 42. Pfizer Business Overview
Table 43. Pfizer Erythropoietin (EPO) Drugs Product
Table 44. Pfizer Revenue in Erythropoietin (EPO) Drugs Business (2017-2022) & (US$ Million)
Table 45. Pfizer Recent Development
Table 46. Roche Company Detail
Table 47. Roche Business Overview
Table 48. Roche Erythropoietin (EPO) Drugs Product
Table 49. Roche Revenue in Erythropoietin (EPO) Drugs Business (2017-2022) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Amgen Company Detail
Table 52. Amgen Business Overview
Table 53. Amgen Erythropoietin (EPO) Drugs Product
Table 54. Amgen Revenue in Erythropoietin (EPO) Drugs Business (2017-2022) & (US$ Million)
Table 55. Amgen Recent Development
Table 56. Johnson & Johnson Company Detail
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Erythropoietin (EPO) Drugs Product
Table 59. Johnson & Johnson Revenue in Erythropoietin (EPO) Drugs Business (2017-2022) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. Kyowa Kirin Company Detail
Table 62. Kyowa Kirin Business Overview
Table 63. Kyowa Kirin Erythropoietin (EPO) Drugs Product
Table 64. Kyowa Kirin Revenue in Erythropoietin (EPO) Drugs Business (2017-2022) & (US$ Million)
Table 65. Kyowa Kirin Recent Development
Table 66. Shanghai Dahua Pharmaceutical Company Detail
Table 67. Shanghai Dahua Pharmaceutical Business Overview
Table 68. Shanghai Dahua Pharmaceutical Erythropoietin (EPO) Drugs Product
Table 69. Shanghai Dahua Pharmaceutical Revenue in Erythropoietin (EPO) Drugs Business (2017-2022) & (US$ Million)
Table 70. Shanghai Dahua Pharmaceutical Recent Development
Table 71. JCR Pharmaceuticals Company Detail
Table 72. JCR Pharmaceuticals Business Overview
Table 73. JCR Pharmaceuticals Erythropoietin (EPO) Drugs Product
Table 74. JCR Pharmaceuticals Revenue in Erythropoietin (EPO) Drugs Business (2017-2022) & (US$ Million)
Table 75. JCR Pharmaceuticals Recent Development
Table 76. Teva Pharmaceuticals Company Detail
Table 77. Teva Pharmaceuticals Business Overview
Table 78. Teva Pharmaceuticals Erythropoietin (EPO) Drugs Product
Table 79. Teva Pharmaceuticals Revenue in Erythropoietin (EPO) Drugs Business (2017-2022) & (US$ Million)
Table 80. Teva Pharmaceuticals Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Erythropoietin (EPO) Drugs Market Share by Type: 2021 VS 2028
Figure 2. Epoetin-alfa Features
Figure 3. Darbepoetin-alfa Features
Figure 4. Global Erythropoietin (EPO) Drugs Market Share by Application in 2021 & 2028
Figure 5. Hospitals Case Studies
Figure 6. Homecare Case Studies
Figure 7. Specialty Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Erythropoietin (EPO) Drugs Report Years Considered
Figure 10. Global Erythropoietin (EPO) Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Erythropoietin (EPO) Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Erythropoietin (EPO) Drugs Market Share by Region: 2021 VS 2028
Figure 13. Global Erythropoietin (EPO) Drugs Market Share by Players in 2021
Figure 14. Global Top Erythropoietin (EPO) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erythropoietin (EPO) Drugs as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Erythropoietin (EPO) Drugs Revenue in 2021
Figure 16. North America Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Erythropoietin (EPO) Drugs Market Share by Country (2017-2028)
Figure 18. United States Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Erythropoietin (EPO) Drugs Market Share by Country (2017-2028)
Figure 22. Germany Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Erythropoietin (EPO) Drugs Market Share by Region (2017-2028)
Figure 30. China Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Erythropoietin (EPO) Drugs Market Share by Country (2017-2028)
Figure 38. Mexico Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Erythropoietin (EPO) Drugs Market Share by Country (2017-2028)
Figure 42. Turkey Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Erythropoietin (EPO) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Pfizer Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2017-2022)
Figure 45. Roche Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2017-2022)
Figure 46. Amgen Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2017-2022)
Figure 47. Johnson & Johnson Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2017-2022)
Figure 48. Kyowa Kirin Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2017-2022)
Figure 49. Shanghai Dahua Pharmaceutical Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2017-2022)
Figure 50. JCR Pharmaceuticals Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2017-2022)
Figure 51. Teva Pharmaceuticals Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2017-2022)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.